Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials | AlphaStreet
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical firm engaged within the improvement of focused radiotherapeutics for difficult-to-treat cancers. Presently, it's ...